Health Care Archives - Page 398 of 478

1 minute read

Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System

October 4, 10:21 AM

Autolus Therapeutics plc (NASDAQ:AUTL) has entered into an agreement with Bristol-Myers Squibb Co (NYSE:BMY). The agreement grants Bristol Myers Squibb access to incorporate Autolus’…

AUTL

1 minute read

Inhibrx’s Experimental Drug For Inherited Disease Capable For Accelerated FDA Approval, Shares Surge

By Vandana Singh

October 4, 9:28 AM

Based on discussions with the FDA, Inhibrx Inc (NASDAQ:INBX) has the potential to pursue accelerated approval for INBRX-101 for emphysema due to…

INBX

1 minute read

KalVista Shares Plunge After Ending KVD824 HAE Trial Over Elevated Liver Enzymes In Patients

By Vandana Singh

October 4, 9:19 AM

KalVista Pharmaceuticals Inc (NASDAQ:KALV) has terminated the KOMPLETE phase 2 trial for KVD824 to prevent attacks in people with hereditary angioedema…

KALV

1 minute read

Adamis Pharmaceuticals Seeks Strategic Options, Including Sale

By Vandana Singh

October 4, 6:27 AM

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) has initiated a process to explore a range of strategic and financing alternatives. The move follows the recently…

ADMP

1 minute read

US Supreme Court Turns Away Biogen’s Last Effort To Reinstate Tecfidera Patent

By Vandana Singh

October 3, 2:14 PM

The U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen Inc's (NASDAQ: BIIB) blockbuster drug Tecfidera.

BIIB

2 minute read

Aura Biosciences Details Interim Data From Mid-Stage Study Of Ocular Oncology Drug

By Vandana Singh

October 3, 1:37 PM

Aura Biosciences Inc (NASDAQ:AURA) detailed interim data from its ongoing Phase 2 trial of an eye cancer drug, elzupacap sarotalocan (AUâ€‘011).…

AURA

1 minute read

Venus Concept Taps Endo’s Former CEO As New Chief Executive, Withdraws FY22 Guidance

By Vandana Singh

October 3, 1:36 PM

Venus Concept Inc (NASDAQ:VERO) appointed Rajiv De Silva as the company’s CEO and board member, effective October 2. The company…

ENDPQ

1 minute read

Clovis Oncology’s Rubraca Hits Primary Goal In Prostate Cancer Settings

By Vandana Singh

October 3, 1:35 PM

Clovis Oncology Inc (NASDAQ:CLVS) announced topline data from the Phase 3 TRITON3 trial, demonstrating that Rubraca monotherapy treatment significantly improved radiographic…

CLVS

1 minute read

BioCardia’s Heart Failure Cell Therapy Shows 100% Survival At Two Years

By Vandana Singh

October 3, 1:33 PM

BioCardia Inc (NASDAQ:BCDA) announced data from its CardiAMP Cell Therapy for Heart Failure pivotal trial. “The two-year outcomes for patients with…

BCDA

1 minute read

Investigator Says Apellis’ Lead Product Shows ‘First Direct Evidence Of Slowing Geographic Atrophy Lesion Growth’

By Vandana Singh

October 3, 11:38 AM

Apellis Pharmaceuticals Inc (NASDAQ:APLS) announced new data from the 24-month Phase 3 OAKS study of pegcetacoplan for geographic atrophy (GA) secondary…

APLS